A1RG34:BVMF
Argenx Se Bdr
R$ 187.38
arrow_upward
+1.99%(+3.65) Siku 1
6 Okt, 16:56:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya A1RG34...
Fungua
R$ 187.38
Juu
R$ 187.38
Chini
R$ 187.38
Mtaji wa soko
51.97B
Wastani wa kiasi cha mauzo
57.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 213.15
Chini kwa wiki 52
R$ 143.22
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Fungua
R$ 187.38
Juu
R$ 187.38
Chini
R$ 187.38
Mtaji wa soko
51.97B
Wastani wa kiasi cha mauzo
57.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 213.15
Chini kwa wiki 52
R$ 143.22
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
dakika 55 zilizopita
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
saa 11 zilizopita
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
saa 11 zilizopita
A drug-delivery partnership expands from six exclusive targets to eight.
AD HOC NEWS
·
saa 15 zilizopita
argenx stock: New VYVGART data span myasthenia gravis and CIDP
Wasifu
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Kuhusu Argenx Se Bdr
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.86
Lilianzishwa25 Apr 2008
Makao makuu-
Sekta-
Tovutiargenx.com